ABSTRACT -Background and Objectives: Negative symptoms emerge in many patients with psychotic disorders long before the onset of the acute illness. These symptoms are often impossible to differentiate from certain Cluster A personality traits.
Introduction
Schizophrenia and other psychotic disorders are heterogeneous conditions that are best understood as complex 1 , lifelong disorders 2 . Approaches to the study of the symptomatology of schizophrenia have not rendered a definitive profile of the characteristic manifestations of this disorder. Polythetic definitions, such as those included in the Diagnostic Statistical Manual and ICD-10 classification systems, continue to govern the process of establishing a diagnosis of schizophrenia.
There has not been one clinical entity, syndrome or dimension within the realm of psychosis that has been externally validated. However, negative symptoms are usually considered closer in relation to neurobiological substrates than other symptomatologic domains. Nevertheless, negative symptoms are neither necessary nor sufficient criterion to diagnose a schizophrenic disorder. Negative symptoms are not uncommon in other mental (e.g., Depressive episodes) and brain disorders (e.g., Alzheimer's Disease). The presence of negative symptoms has been demonstrated in relatives of many schizophrenia patients 3 . It is often assumed that negative symptoms are abnormal conditions, but normative studies have not been conducted. In addition, negative symptoms are very close to the specific criteria for a number of personality disorders (i.e., Schizoid, Avoidant and Schizotypal personality disorders) 4, 5 .
The latter statement lends support to the assertion that not all patients begin psychotic episodes with the same level of intensity of negative symptoms. To label these negative symptoms, Tandon et al. 6 coined the term premorbid negative symptoms. In comparison, primary negative symptoms, on grounds of hypothesized causality, are best understood as the negative symptoms that are displayed at the onset of the acute episode of the illness, after ruling out the contribution of potential secondary sources of negative symptoms. Therefore, the negative symptomatology of the first acute episode is characterized by the addition of the primary negative symptoms to the premorbid negative symptoms plus other negative symptoms caused by other conditions (e.g., depressive anhedonia, social isolation or neuroleptic akinesia). The primary negative symptoms are considered illness-related symptoms that may respond, at least in part, to antipsychotic treatment [7] [8] [9] . Nonrespondent or residual primary negative symptoms were predicted mainly by the primary negative symptoms, after controlling for other potential contributors, such as depression, neuroleptic-induced extrapyramidal side effects, social isolation and other factors [10] [11] [12] [13] . However, studies have not been conducted to address the extent to which premorbid negative symptoms determine further negative symptomatology over the course of the illness. Different approaches can be taken to delineate the influence of premorbid negative symptoms on primary and secondary negative symptoms, although follow-up studies are the most appropriate method to employ. However, the presence of negative symptoms can be traced back using indirect approaches, such as the assessment of premorbid personality. Premorbid personality traits are currently reliably quantified through modern semi-structured interviews. These traits are nearly identical to certain negative symptomatologic domains; therefore the assessment of premorbid personality traits might be used as a proxy measure of an individual's premorbid negative symptomatology.
Previous studies from our group and others have demonstrated a close relationship between premorbid personality dimensions and the symptomatology of acute episodes in samples of individuals with both chronic and recent-onset psychosis [14] [15] [16] [17] . A common limitation in the literature on premorbid personality, including one of our previous studies 18 was that negative symptomatology was examined during the remission of the acute episode. Thus, only residual negative symptoms were addressed without controlling for primary symptomatology. In an effort to overcome this shortcoming and to develop a better understanding of the origin and nature of negative symptoms in early psychosis, it is essential to not only control for the effects of secondary negative symptoms, but also for the contribution of primary negative symptoms and other potential causes of negative symptomatology. We hypothesized that certain domains of the premorbid personality are true expressions of premorbid negative symptoms.
Methods

Participants
Participants were 84 inpatients at Santiago Apóstol Hospital, an acute psychiatric unit in Vitoria, Spain. The patients were referred to the study because they had experienced a first-episode of acute psychosis. Acute psychotic episodes were defined by a score of 4 or greater on any of the following three items on the Positive and Negative Syndrome Scale (PANSS) 19 : delusions, conceptual disorganization, or hallucinatory behavior. Diagnosis was based on the Structured Clinical Interview for DSM-IV (SCID) 20 . Patients were assigned to the following DSM-IV diagnostic categories 21 :
Schizophrenic Disorder (n = 28), Schizophreniform Disorder (n = 11), Brief Psychotic Disorder (n = 18), Delusional Disorder (n = 7), Manic Disorder with Psychotic Symptoms (n = 18) and Major Depressive Disorder with Psychotic Symptoms (n = 2).
Patients were between 18 and 65 years of age. Exclusion criteria included systemic or neurological illness, history of head trauma, and substance dependence. Ten patients were excluded because they had previously received anti-psychotic drugs. As a result, the final study sample consisted of 84 neuroleptic-naïve psychotic patients. An exhaustive investigation of previous drug treatments was conducted through information obtained from various sources (i.e., patient, relatives). Primary physician records were tracked when it was deemed necessary. All patients gave written informed consent before entering the study.
Design and Assessments
This study consisted of a reanalysis of data from a previous study 22 , which examined the relationships between premorbid personality dimensions and psychopathological dimensions at discharge. Three innovations were introduced in the present study in order to advance the understanding of the origin of negative symptoms in psychosis and to justify the present re-analysis. First, negative symptomatology at admission was included as a measure of primary negative symptoms in the statistical procedures, after accounting for by the remaining potential causes of negative symptoms at this initial assessment. Second, the premorbid personality dimensions were used as a proxy measure of premorbid negative symptoms. And third, only the neuroleptic-naïve subset of first episode psychotic patients was included in order to avoid interference in the assessment of premorbid personality. The design of this study enabled us to have three methods of the assessment of negative symptoms in order to answer our main research question: Were premorbid negative symptoms predictive of the intensity of residual negative symptomatology, after controlling for the influence of primary negative symptomatology?
Psychopathological symptoms were assessed with the Spanish adaptation of the PANSS. Participants were assessed on admission to the psychiatric unit (T1) and at discharge from hospital (T2). As reported by Marder et al. 23 , we chose the five-dimensional model of the PANSS in order to extract the PANSS underlying dimensions. This model was comprised of the following dimensions: negative, psychotic, disorganization, excited and depressive. Neurolepticinduced extrapyramidal side effects were assessed at T2 by means of the total score on the Simpson-Angus Rating Scale 24 . The first author, MC, conducted all of the PANSS and Simpson-Angus Rating scale assessments.
The Personality Assessment Schedule (PAS) 25 was used to assess Premorbid Personality (PP). The PAS is a structured interview that evaluates 24 personality variables on a 9-point scale of intensity. An individual's score on each personality variable depends on the influence that the specific variable has had on their functioning over the course of their life. The PAS interview allows for the extraction of four clusters of personality traits: passive-dependent, obsessional, schizoid, and sociopathic. As we previously reported 18 the PAS interview was partially modified to differentiate a schizotypic dimension.
In an attempt to avoid interference with current symptoms, we chose the patient's mother or father as the main informant. In order to collect measures of enduring personality characteristics, the questions that informants were asked about a participant's personality placed special emphasis on the premorbid period. As recommended by other researchers 26 , the premorbid period was defined as one year before the appearance of any prodromic manifestation or any noticeable clinical symptom. PG, who was blind to the psychopathological status of patients, administered the PAS interview.
Statistical Analysis
Psychopathological at both assessment points and personality scores were examined by means of the Kolmogorov-Smirnoff test. This statistical procedure was used to transform non-normally distributed scores to logarithm scaling in order to achieve normality. The first step of the statistical analysis used Spearman rank coefficient correlations to examine the associations between negative symptomatology at T2, later referred to in the text as 'residual' or 'nonrespondent' negative symptomatology, and its potential contributing factors. The latter included premorbid personality dimensions, symptomatological dimensions at admission, Simpson-Angus total score and nonnegative symptomatological dimensions at T2.
Stepwise linear regression analysis was then employed to determine the particular contributions of the variables that were found to be significantly associated with residual negative symptoms in the former correlational analysis. The coefficient of determination (R 2 ), added at each step and multiplied by 100, was used to designate the proportion of variance in residual negative symptoms (dependent variable) accounted for by its predictors. Measurement error that was not explained by the secondary sources of negative symptoms might also contribute to variability in the negative symptoms.
Results
The demographic and clinical variables of the patients are presented in Table I . As expected, there were significant differences between admission and discharge scores on the five psychopathological dimensions of the PANSS scale.
Associations between residual negative symptomatology and premorbid personality dimensions, psychopathological dimensions at T1 and T2, and total score of the Simpson-Angus scale are shown in Table II . Significant correlation coefficients were found between residual negative symptomatology and the following scores: premorbid personality dimensions of schizoid, passive-dependent and schizotypic, negative and disorganization symptoms at T1, disorganization and depressive symptoms at T2 and the total score of the Simpson-Angus scale at T2. The variables that had significant correlation coefficients with residual negative symptomatology were entered further in the regression analysis.
Forty-two percent of the variance in residual negative symptoms was accounted for by primary negative symptoms. At steps 2 and 3, disorganization symptoms at T2 (Adjusted R 2 = .13) and depressive symptoms at T2 (Adjusted R 2 = .05) were entered into the analysis. And finally, the schizoid premorbid personality dimension score predicted five percent of the variance in residual negative symptoms (Adjusted R 2 = .05).
Discussion
Residual or 'non-respondent' negative symptoms were strongly predicted by primary negative symptoms. Primary negative symptoms are hypothetically related to the illness process. Other symptom domains, such as disorganization and depressive symptoms at discharge (T2), were also moderately, but significantly, associated with residual negative symptoms. These results were in accordance with previous results that we obtained with the data set from a different sample 9 . However, a novel finding in the current study was that not only did schizoid premorbid traits slightly, but significantly, predict the intensity of residual negative symptoms, but also that this effect persisted after controlling for the effect of the primary negative symptoms, other non-negative symptom domains at admission and discharge and the SimpsonAngus total score at discharge. To our knowledge, this study is the first to examine the contribution of premorbid negative symptoms to the differentiation between primary and residual negative symptomatology in psychosis.
Several explanations, referenced in works from classic literature to recent articles, have been proposed to account for the relationships between personality and the symptomatology of psychosis 5, 13, 22 . Briefly, premorbid personality has been considered to be a modulator, or pathoplastic agent, on schizophrenia symptoms, a comorbid disorder within Axis II 21 , a scar or residual symptomatology from earlier subthreshold psychiatric episodes, and a risk factor for developing psychosis. Collectively, these explanations provide for a more thorough understanding of these constructs. Our present design does not allow for a definitive testing of the goodness of fit of these models. However, studies of people at high-risk for psychosis that later develop first episode psychosis suggest that schizoid and other types of personality traits are risk factors for the development of schizophrenia 27 . As reported in schizotaxia 28 , predispositional states to schizophrenia, defined by the presence of negative symptoms, seem to be part of the genetic background to the illness. In our study, personality traits included within the schizoid dimension on the PAS were introspection, shyness and aloofness. These personality traits are considered very common in people at high-risk for psychosis. A comorbidity model is a simplistic view used to explain the coexistence of personality and symptomatologic domains. A comorbidity model would be valid in terms of description but it does not provide an underlying explanation. Another proposed model is the scar model, which maintains that personality traits would be secondary to a previous subthreshold or clinical episode. The latter seems to be an unlikely model for our study, since our sample consisted of patients experiencing their first psychotic episode.
Finally, the present results were in accordance with a pathoplastic contribution of premorbid personality traits to residual negative symptoms. An estimation of the contribution of premorbid personality traits was possible after we controlled for primary and secondary sources of negative symptomatology. This resulting estimation indicated that there was a small, but statistically significant contribution of premorbid schizoid traits to residual negative symptomatology in psychosis (about 5% of the explained variance).
Our study also found that disorganization and depressive symptoms at discharge were moderate, but significantly associated with residual negative symptoms. However, this finding indicates more of an overlapping of psychopathological domains than of a true predictor effect, since depressive and disorganization dimensions at admission did not predict residual negative symptomatology. Moreover, medium to high correlations between these psychopathological dimensions are usual in clinical populations.
Several methodological limitations of the study warrant discussion. First, there is a wealth of evidence to suggest that a wide range of premorbid deviations precede the beginning of psychosis, therefore blurring the boundaries between premorbid and prodromal phenomena 29 . However, in accordance with suggestions made by other authors 26 we chose the time frame of one year prior to the occurrence of noticeable prodromic or clinical symptoms as an arbitrary point for the establishment of the premorbid period. Second, as identified by other authors 6 residual negative symptoms were defined as the negative symptoms that remained after the remission of the first psychotic episode (i.e. at discharge). Ideally, it would have been better to have a longer follow-up period, since many symptoms continue to improve beyond the resolution of the acute episode. Another potential shortcoming in this study was that extrapyramidal signs were not assessed at intake and could not be introduced into the regression analysis procedures. However, in a previous study conducted with a different sample, extrapyramidal symptomatology at intake did not significantly predict negative symptomatology at discharge 9 . Fourth, two potential causes of secondary negative symptomatology (e.g., chronicity and social isolation) were not included in our study. However, both chronicity and social isolation are sources of negative symptomatology, which usually emerge after successive episodes and not during the first episode of the illness. Fifth, the mixed diagnostic nature of sample, with predominance of schizophrenia disorders, would have biased the results regarding the negative symptomatology. However, by excluding affective patients (n = 20) the same significant associations, both in correlation and regression procedures, were found.
In summary, residual negative symptomatology was strongly associated with the primary negative or illness-related symptomatology (42% of explained variance). This strong, preceding relationship suggests a possible causal role for primary negative over 'non-respondent' negative symptomatology. Moreover, an additional 20% of the explained variance in residual negative symptomatology resulted from the overlapping effect of disorganization dimension at T2 and depressive dimension at T2 (13% and 5% of explained variance, respectively). Finally, the schizoid dimension of premorbid personality explained 5% of the variance in residual negative symptomatology. As a result, premorbid personality can be considered to be a true expression of the premorbid negative symptomatology.
